In one paragraphArticle in Marine drugs, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from itWhat it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
10 authors.
Ana JesusAssociate Laboratory i4HB-Institute for Health and Bioeconomy, Faculty of Pharmacy, University of Porto, 4050-313 Porto, Portugal.
Sara Gimondi3B's Research Group, I3BS-Research Institute on Biomaterials, Biodegradables and Biomimetics, University of Minho, AvePark, Parque de Ciência e Tecnologia, Rua Ave 1, Edificio 1 (Sede), Barco, 4805-694 Guimarães, Portugal.
Sónia A PinhoCNC-Center for Neuroscience and Cell Biology, Centre for Innovative Biomedicine and Biotechnology (CIBB), 3004-504 Coimbra, Portugal.ORCID 0000-0002-7426-5197 Helena Ferreira3B's Research Group, I3BS-Research Institute on Biomaterials, Biodegradables and Biomimetics, University of Minho, AvePark, Parque de Ciência e Tecnologia, Rua Ave 1, Edificio 1 (Sede), Barco, 4805-694 Guimarães, Portugal.ORCID 0000-0002-3770-9393 Nuno M Neves3B's Research Group, I3BS-Research Institute on Biomaterials, Biodegradables and Biomimetics, University of Minho, AvePark, Parque de Ciência e Tecnologia, Rua Ave 1, Edificio 1 (Sede), Barco, 4805-694 Guimarães, Portugal.ORCID 0000-0003-3041-0687 Andreia PalmeiraLaboratory of Organic and Pharmaceutical Chemistry, Department of Chemical Sciences, Faculty of Pharmacy, University of Porto, Rua de Jorge de Viterbo Ferreira, 288, 4050-313 Porto, Portugal.ORCID 0000-0002-1391-2143 Emília SousaLaboratory of Organic and Pharmaceutical Chemistry, Department of Chemical Sciences, Faculty of Pharmacy, University of Porto, Rua de Jorge de Viterbo Ferreira, 288, 4050-313 Porto, Portugal.ORCID 0000-0002-5397-4672 Isabel F AlmeidaAssociate Laboratory i4HB-Institute for Health and Bioeconomy, Faculty of Pharmacy, University of Porto, 4050-313 Porto, Portugal.ORCID 0000-0002-1498-048X Maria T CruzCNC-Center for Neuroscience and Cell Biology, Centre for Innovative Biomedicine and Biotechnology (CIBB), 3004-504 Coimbra, Portugal.ORCID 0000-0001-9846-6754 Honorina CidadeLaboratory of Organic and Pharmaceutical Chemistry, Department of Chemical Sciences, Faculty of Pharmacy, University of Porto, Rua de Jorge de Viterbo Ferreira, 288, 4050-313 Porto, Portugal.ORCID 0000-0003-0715-1779 Funding
INSTRUMENTAL ANALYSISZ01CT000014 · CIT · COMPUTER RESEARCH AND TECHNOLOGY · PI WEISS, GEORGE H · 1985 to 2008
$408kFundação para a Ciência e Tecnologia Ana Jesus acknowledges her Ph.D. grant with doi:10.54499/UIDP/04378/2020, totally financed by FCT.Fundação para a Ciência e Tecnologia in the scope of the projects https://doi.org/10.54499/UIDP/04378/2020 and https://doi.org/10.54499/UIDP/04378/2020 of the Research Unit on Applied Molecular Biosciences - UCIBIOFundação para a Ciência e Tecnologia the European Regional Development Fund (ERDF), through the Centro 2020 Regional Operational Programme under project CENTRO-01-0145-FEDER-000012 (HealthyAging2020)Fundação para a Ciência e Tecnologia the project https://doi.org/10.54499/UIDP/04378/2020 of the Associate Laboratory Institute for Health and Bioeconomy - i4HBFundação para a Ciência e Tecnologia the projects UIDP/04539/2020, and the projects UIDP/04539/2020 and LA/P/0058/2020 from CIBBFundação para a Ciência e Tecnologia the project "TERM RES Hub - Scientific Infrastructure for Tissue Engineering and Regenerative Medicine" (PINFRA/22190/2016, Norte-01-0145-FEDER-022190), co-funded by FCT and the CCDRN)Fundação para a Ciência e Tecnologia the Sara Gimondi Individual Scientific Employment Stimulus grant (2023.06754.CEECIND/CP2841/CT0014)Fundação para a Ciência e Tecnologia the scope of the Strategic Funding UIDB/04423/2020 (https://doi.org/10.54499/UIDB/04423/2020), UIDP/04423/2020 (https://doi.org/10.54499/UIDP/04423/2020), and LA/P/0101/2020 (https://doi.org/10.54499/LA/P/0101/2020)Intramural NIH HHS Z01 CT000014
6 · The paper itselfAbstract
Skin aging is mainly caused by external factors like sunlight, which triggers oxidative stress and chronic inflammation. Natural halogenated flavonoids have demonstrated anti-inflammatory properties. Inspired by the macroalgae-derived bromophenol
Indexed as
Anti-Inflammatory AgentsChalconesCosmeticsSeaweedSkin AgingAnimalsHumansInflammationKeratinocytesMacrophagesMiceNF-E2-Related Factor 2Nitric Oxide Synthase Type IIRAW 264.7 CellsStructure-Activity RelationshipAnti-Inflammatory AgentsChalconesCosmeticsNF-E2-Related Factor 2Nitric Oxide Synthase Type IIanti-inflammatory activitybrominated chalconesiNOSmacroalgaeNrf2skin aging
Identifiers
PMID40710503
PMCPMC12299847
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390